EGETIS THERAPEUTICS AB NPV revenue for the last year amounted to 57.60 M SEK, the most of which — 21.90 M SEK — came from its highest performing source at the moment, Emcitate, the year earlier bringing 15.65 M SEK. The greatest contribution to the revenue figure was made by Other Countries — last year it brought EGETIS THERAPEUTICS AB NPV 4.50 M SEK, and the year before that — 5.73 M SEK.